References
- Kopera H, Utian WH. Twenty five years of hormone replacement therapy. Maturitas 1990; 12: 159–319
- Hunter MS. Emotional well-being, sexual behaviour and hormone replacement therapy. Maturitas 1993; 15: 299–314
- Veeninga A T, Kraimaat FW. A multifactorial approach to complaints during the climacteric. J Reprod Inf Psychol 1995; 13: 69–77
- Dennerstein L, Burrows G D, Wood C, et al. Hormones and sexuality: effect of estrogen and progestogen. Obstet and Gynecel 1980; 56: 316–22
- Rymer J, Chapman M G, Fogelman I, et al. A study of the effect of tibolone on the vagina in postmenopausal women. Maturitas 1994; 18: 127–33
- Genazzani A R, Petraglia F, Facchinetti F, et al. Steroid replacement treatment increases beta-endorphin and beta-lipoprotein levels in post menopausal women. Gynaecol Obstet Invest 1988; 26: 153–59
- Gregoire A JP, Kumar R, Everitt B, et al. Transdermal oestrogen for treatment of severe postnatal depression. Lancet 1996; 47: 930–3
- Chakravarti S, Collins W P, Thorn M H, et al. Relation between plasma hormone profiles, symptoms and response to oestrogen treatment in women approaching the menopause. Br Med J 1979; 1: 983–85
- Pearce J, Hawton K, Blake F. Psychological and sexual symptoms associated with the menopause and the effects of hormone replacement therapy. Br J Psychiatry 1995; 167: 163–73
- Ross L A, Alder EM. Tibolone and climacteric symptoms. Maturitas 1995; 21: 127–36
- Foidart J-M, Beliard A, Hedon B, et al. Impact of percutaneous oestradiol gels in postmenopausal hormone replacement therapy on clinical symptoms and endometrium. Br J Obstet Gynaecol 1997; 104: 305–10
- Alder E. The Blatt-Kupperman Menopausal Index: a critique. Maturitas 1998; 29: 19–24
- Winkler U H, Helmond F, Coelingh Bennick H. Effects of Livial and Kliogest on climacteric symptoms and endocrinological parameters: a randomised double blind study. Acta Obstet Gynecol Scand Suppl 1997; 76: 5–57, Suppl 167
- Yang T S, Ng HG. Preliminary report of the effects of HRT on the Chinese early postmenopausal effects of HRT: conjugated estrogen plus medroxyprogesterone versus tibolone. Acta Obstet Gynecol Scand Suppl 1997; 76: 5–58
- Hunter M. The Women's Health Questionnaire: a measure of mid-aged women's perception of their emotional and physical health. Psychol Health 1992; 7: 45–54
- Snaith R P, Constantopoulous A A, Jardine M Y, et al. A clinical scale for the self assessment of irritability. Br J Psychiat 1978; 132: 164–71
- Greene JG. Guide to the Greene Climacteric Scale. University of Glasgow, Glasgow 1991
- Richardson P. Placebos: their effectiveness and modes of action. Health Psychology Process and Applications, 2nd edn., A Broome, S Llewelyn. Chapman and Hall, London 1995; 35–51
- Gangar K, Cust M, Whitehead ML. Symptoms of oestrogen deficiency associated with supraphysiological plasma oestradiol concentrations in women with oestradiol implants. Br Med J 1989; 299: 601–2
- Alder E M, Bancroft J, Livingstone J. Estradiol implants, and reported symptoms. J Psychosom Obstet Gynecol 1992; 13: 23–235
- Dennerstein L, Dudley E, Burger H. Well-being and the menopause transition. J Psychosom Obstet Gynecol 1997; 18: 95–101
- Medical Research Council's General Practice Research Framework. Randomised comparison of oestrogen versus oestrogen plus progestogen hormone replacement therapy in women with hysterectomy. Br Med J 1996; 312: 473–8
- Palacios S, Menendez C, Jurado A R, et al. Changes in sex behaviour after menopause: effects of tibolone. Maturitas 1995; 22: 155–161